Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Three recommendations suggest monotherapy options for preventing episodic migraine headache in outpatient settings
Read More »ACP Issues Clinical Guideline for Pharmacologic Prevention of Episodic Migraine
Body Weight Cycling Tied to Increased Risk for Renal Events in Type 1 Diabetes
Authors say that long-term weight maintenance should be a focus of this population
Read More »Salt Substitution Cuts Risk for Recurrent Stroke
Additionally, during more than five years of follow-up, risk for stroke-related death also reduced
Read More »ASA: Mechanical Removal of Clot No Better Than Best Medical Treatment for Medium or Distal Vessel Occlusion
Two studies show endovascular thrombectomy does not lead to better outcomes at 90 days or result in lower incidence of death
Read More »Effect of Behavioral Intervention on Reducing Care Overuse in Seniors Not Sustained
Persistence of effects of behavioral intervention in older adults varies after discontinuation of intervention
Read More »Possible Listeria Contamination Prompts Recall of 2 Million Baked Goods
Manufacturer says recall was completed in early January and 'does not implicate anything that is currently, or was recently, on the market'
Read More »Concentrations of Selected PFAS Up in Firefighters After 2023 Maui Wildfires
Firefighters had higher serum concentrations of some PFAS than employees from other occupations, but mainly below threshold for screening
Read More »Nutrition Label Policies May Have Negative Impact on People With Eating Disorders
Association noted for eating disorder pathology with noticing labels more frequently, more frequent changes in behavior due to caloric values
Read More »New Facial Plastic Surgery Survey Illustrates Impact of GLP-1 Receptor Agonists
GLP-1 receptor agonists driving growing demand for nonsurgical treatments to address 'Ozempic face'
Read More »Study Finds Exenatide Not Beneficial for Parkinson Disease
No evidence seen to support GLP-1 receptor agonist exenatide as disease-modifying treatment for Parkinson disease
Read More »